A medical software company just launched an ad campaign that parodies drug commercials. That joke only works because the category grew up. This issue follows health AI from the ad break to the trial data.
The drug ads are for software now
Australian scribe company Heidi is running a global campaign styled like pharma advertising, promising clinicians relief from documentation. When software markets itself like medicine, it is claiming medicine’s territory. See the campaign →
The ads work because the product does
Scribes became near-standard in US health systems faster than any clinical software in memory. How they actually work, and their honest failure modes, from someone who has used them on real patients. The physician’s guide →
Upstream, the molecules moved
Documentation is the shallow end. In Cambridge, an AI-designed vaccine built to cover the entire sarbecovirus family, not one strain, just completed its first human safety trial. Read the result →
And the first AI drug reached the deep end
Insilico’s Rentosertib, AI-identified target and AI-generated molecule, is now in Phase 3 for pulmonary fibrosis, with a Takeda deal worth up to $600 million behind it. The pipeline is no longer hypothetical. A physician’s read →
Second Opinion
The physician’s read on the week: when a medical tool advertises like a drug, evaluate it like one. The claim that matters is not minutes saved, it is error rate under fatigue, and no ad prints that number. Ask for it anyway. What to ask →
One number
39. The volunteers in the vaccine’s Phase I trial. Small number, enormous door. Why it matters →
One thing to use
AI drug discovery, decoded. What the technology actually does versus what press releases claim, from a physician. Read it before the next breakthrough headline finds you. Get literate →
That is the thread: the marketing grew up, the products earned it, and the molecules are in humans now. Hit reply with your clinic’s AI story; I collect them. Forwarded this? Claim your own copy.
Dr. Joseph Joshua
P.S. Next issue: 4,800 jobs and one apology.
AI and business tech news, verified by a physician who reads the filings. One email a week, no noise.
